EB13ICD-11 MMS 2026-01
Stevens-Johnson syndrome or toxic epidermal necrolysis
Description
A spectrum of severe and life-threatening hypersensitivity disorders affecting skin and mucous membranes, most commonly precipitated by an idiosyncratic reaction to medication. Stevens-Johnson syndrome (SJS) always involves mucosal surfaces but the skin involvement is limited by definition to <10% body surface area (BSA). Toxic epidermal necrolysis (TEN) may sometimes spare mucous membranes but skin involvement is by definition >30% BSA. An intermediate form is recognised in which mucosal involvement is accompanied by skin involvement of 10-30% BSA (SJS-TEN overlap syndrome). All forms result in extensive sloughing and ulceration and carry a significant risk of fatal outcome.
Index terms
- Stevens-Johnson syndrome or toxic epidermal necrolysis
- SJS/TEN - [Stevens-Johnson syndrome and toxic epidermal necrolysis]
Exclusions from above levels
1B72.0– Bullous impetigo of the napkin area1F23.12– Napkin candidosisEH71– Dermatoses precipitated by drug therapy
Show allHide
EH76– Dermatoses associated with specific classes of medication
Child codes
Foundation children elsewhere
EH63– Stevens-Johnson syndrome or toxic epidermal necrolysis due to drug
Sibling codes
Foundation entity
Stevens-Johnson syndrome or toxic epidermal necrolysis – http://id.who.int/icd/entity/195467267
Part of: 14: Diseases of the skin